An International Unit, abbreviated IU, is a standardized measure of a substance’s biological activity rather than its physical weight. One IU of vitamin D, for instance, does not equal one IU of insulin or one IU of vitamin A, because each substance has its own IU definition tied to how potent it is in the body. The system exists because for many biological substances, knowing how many milligrams you have tells you surprisingly little about what that amount will actually do. The story behind why that is the case, and how IU values get assigned, is more interesting and more practically relevant than most people realize.
Why Weight Alone Is Not Enough
For a simple chemical like table salt, weight is a perfectly reliable way to measure a dose. A milligram of sodium chloride is a milligram of sodium chloride, and it behaves the same way every time. Biological substances are different. A hormone, a vaccine antigen, or a vitamin extracted from natural sources can vary in purity, molecular form, and how readily the body uses it. Two batches of the same biological product might weigh the same but differ in how much biological effect they produce. This is the fundamental reason International Units exist: they measure what a substance does, not simply how much of it sits on a scale.
The distinction matters most for substances that are complex molecules or come in multiple chemical forms. Vitamin E, for example, exists in several molecular varieties, some of which are more biologically active than others. Vitamin D comes in at least two major forms with different potencies. Insulin extracted from animal pancreases varied in purity from batch to batch in the early twentieth century, making weight-based dosing unreliable and sometimes dangerous. The IU system was developed to solve exactly this kind of problem: it anchors dosing to a measurable biological effect so that one unit means the same thing regardless of who manufactured the product or where it was made.
How the System Got Started
The IU concept traces back to the early 1920s, born out of urgent practical need. In 1922, the Ehrlich antitoxin was adopted as the First International Standard for diphtheria antitoxin, with its activity defined in International Units. European laboratories participating in collaborative studies agreed to adopt this common yardstick so that a dose prescribed in Paris would have the same effect as a dose prescribed in Berlin. By 1928, the same approach was extended to tetanus antitoxin. Around the same time, Sir Henry Dale at the National Institute for Medical Research in London defined the international standard for insulin in IU in 1925, which made the widespread manufacture of safe and effective insulin products possible worldwide.1Journal of Pharmaceutical Sciences. The vital role of biological standardization in ensuring efficacy and safety of biological products – Historical perspectives
Before these standards existed, comparing products from different manufacturers or different countries was essentially guesswork. A doctor ordering antitoxin from one supplier had no reliable way to know whether it was equivalent to the antitoxin from another. The IU system changed that by creating a shared reference point: a physical vial of material, stored under controlled conditions, against which every manufacturer could calibrate their products. That basic architecture remains in place a century later.
How International Units Are Actually Assigned
The process of setting an IU value for a substance is more hands-on than you might expect. The World Health Organization’s Expert Committee on Biological Standardization coordinates the effort, commissioning collaborative studies that involve numerous laboratories worldwide.2PubMed. WHO Expert Committee on Biological Standardization A candidate reference material, typically a carefully prepared batch of the substance in question, is sent to participating labs. Each lab independently measures the material’s biological activity using agreed-upon assays. The results are pooled, and if they show acceptable agreement, the committee assigns the material an official potency value in IU.
The physical reference material itself is then stored, usually at the National Institute for Biological Standards and Control (NIBSC) in the United Kingdom, in carefully maintained conditions. That vial becomes the yardstick. Manufacturers calibrate their working standards against it, and those working standards are in turn used to assign IU values to commercial products. The chain of traceability runs from the product on the pharmacy shelf all the way back to that single reference ampoule.
A concrete example of this process at work: when COVID-19 vaccines arrived, researchers needed a way to compare antibody responses across different vaccine platforms and clinical trials. In December 2020, the WHO established the first International Standard for anti-SARS-CoV-2 immunoglobulin, assigning it a value of 250 IU per ampoule for neutralizing antibody activity. This gave labs around the world a common benchmark so that an antibody measurement from a trial in South Africa could be meaningfully compared with one from a trial in the UK.3The Lancet Microbe. WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific community
IUs You Encounter in Everyday Life
If you have ever read a supplement label, you have seen IU values, most commonly for vitamins A, D, and E. For these vitamins, the IU was historically the standard unit on labels and in dietary guidelines. One IU of vitamin D equals 0.025 micrograms of cholecalciferol (vitamin D3). One IU of vitamin A equals 0.3 micrograms of retinol. These conversion factors are fixed and well established, which means for vitamins, you can convert between IU and micrograms with simple arithmetic.
In fact, for vitamins, the trend has been moving away from IU labeling and toward weight-based units. The U.S. Food and Drug Administration updated its Nutrition Facts label requirements to use micrograms (mcg) for vitamins A and D instead of IU, precisely because the chemistry of these vitamins is now well enough understood that weight-based measurements are reliable. You will still see IU on many supplement bottles because older labeling persists and because some regulations outside the U.S. still use IU, but the direction of travel for vitamins is toward retirement of the unit.
For other substances, however, IU remains essential and is not going anywhere. Insulin, vaccines, blood clotting factors, certain hormones, and some antibiotics are still measured in IU because the biological-activity argument holds: weight alone does not capture what you need to know about how these substances perform.
Insulin and the IU
Insulin is probably the substance most people associate with International Units, and for good reason. Every person with type 1 diabetes and many with type 2 diabetes dose their insulin in units, multiple times a day, every day. The conventional concentration of insulin is expressed in IU per milliliter (IU/mL), a bioefficacy-based measurement, as opposed to the SI system’s mass-based unit of picomoles per liter.4PubMed Central. Insulin Units and Conversion Factors: A Story of Truth, Boots, and Faster Half-Truths
The reason insulin sticks with IU rather than switching to a weight-based unit is partly historical momentum and partly practical safety. Patients, clinicians, and insulin pump manufacturers have built an entire ecosystem around the unit. Changing to micrograms or nanomoles would require recalibrating every insulin pen, every pump, and every dosing guideline worldwide, with enormous potential for confusion and dosing errors during the transition. The IU system works well for insulin, and nobody is in a hurry to replace it.
Standard insulin in most of the world is formulated at U-100, meaning 100 IU per milliliter. Concentrated formulations like U-200, U-300, and U-500 exist for patients who need larger doses, and the IU labeling helps ensure that a patient switching between concentrations can still dose correctly. A patient prescribed 30 units draws a different volume from a U-100 vial than from a U-500 vial, but the biological effect is intended to be the same 30 units either way.
Blood Clotting Factors
People with hemophilia depend on replacement clotting factors, and these products are dosed in IU. The establishment of the International Standard for factor VIII introduced a common yardstick that all countries could apply, making it possible to define diagnostic and therapeutic criteria with much more precision than before.5Thrombosis and Haemostasis. Factor VIII International Units and Reference Materials Before this common standard, labs in different countries might measure the same patient’s factor VIII level and get different numbers, making it difficult to set treatment thresholds that applied internationally.
Calibrating these products is not trivial. When laboratories assayed a candidate reference concentrate for factor VIII against the first International Standard, the mean potency came out to about 1.10 IU per ampoule, with no significant difference between the two major assay methods used.6Thrombosis and Haemostasis. An International Collaborative Assay of Factor VIII Clotting Activity That kind of agreement across labs and methods is exactly what the IU system is designed to achieve. The shared reference material ensures that a hemophilia patient in Japan who needs their factor VIII level raised to 50 IU per deciliter receives a dose that produces the same biological effect as it would for a patient in Canada.
Ideally, all factor VIII and factor IX products should be calibrated against the WHO International Standards, because assigning potencies in IU helps maintain meaningful references for manufacturers, patients, and clinicians alike.7PubMed. Considerations on activity assay discrepancies in factor VIII and factor IX products In practice, some newer recombinant products present challenges for existing assays, which is an active area of work in the field.
When Reference Standards Need Replacing
Here is a problem most people never think about: the physical reference material stored in a freezer is a finite resource. Laboratories around the world request samples for calibration, and eventually the supply runs low. The material can also degrade over decades, even under ideal storage conditions. When that happens, a new reference standard must be prepared and calibrated against the outgoing one before the old stock is exhausted.
This replacement process sounds straightforward but introduces real challenges. Maintaining the unit’s meaning across generations of reference materials requires careful collaborative studies, and issues arise when the primary reference must be replaced, particularly in assessing whether the new reference behaves identically to the old one across the range of real-world products it will be used to calibrate.8PubMed. International reference preparations for standardization of biological medicinal products
A specific example illustrates the concern. In a collaborative study to calibrate a replacement International Standard for tetanus toxoid, researchers noted that the number of laboratories performing the traditional guinea pig challenge assay had dropped sharply compared with previous calibration rounds. This shrinking pool of labs capable of running the original assay raises questions about how reliably future replacement standards can be calibrated, and whether switching to mouse-based assays might require defining separate unit values.9PubMed. Collaborative study for the calibration of a replacement International Standard for Tetanus Toxoid Adsorbed In other words, the IU system relies not just on physical materials but on a global network of laboratories with the expertise and equipment to run the right assays, and that network is not guaranteed to persist unchanged.
Biosimilars and Modern Calibration Headaches
The rise of biosimilar drugs, which are the biological equivalent of generic medications, has introduced new calibration challenges for the IU system. A biosimilar must demonstrate that it produces the same biological effect as the original product, and IU-based potency testing is one of the tools used to establish that equivalence. In principle, use of International Units can drive consistency and standardization for biosimilar products across manufacturers.
In practice, things get more complicated. Research during the development of Retacrit (epoetin alfa-epbx), the first biosimilar approved by the FDA for all indications of the original epoetin alfa products, showed that use of a compendial reference standard overestimated the potency of both the biosimilar and the originator product.10PubMed. Reference Standard Calibration Challenges in the Case of Erythropoietin: Impact on Potency and Biosimilarity Determination That finding matters because if the reference standard inflates potency readings, a product could appear to meet its labeled IU value while actually delivering less biological activity than expected. For a drug used to treat anemia in patients undergoing chemotherapy or dialysis, that discrepancy has clinical consequences.
This does not mean the IU system is broken. It means the system requires constant maintenance and vigilance, especially as the landscape of biological products grows more complex. When a reference standard was created for a single product decades ago and is now being used to calibrate products made by different manufacturers using different cell lines and purification processes, the assumption that the standard behaves identically toward all these products needs to be tested rather than taken on faith.
New Reference Materials for New Substances
The WHO and its collaborating institutions do not only maintain old standards; they create new ones as medical science identifies new substances that need standardized measurement. A recent example is anti-Müllerian hormone (AMH), which is used clinically to assess ovarian reserve in fertility medicine. Different commercial immunoassays for AMH were giving different results, making it hard to set universal clinical cutoffs. A WHO Reference Reagent was established with a consensus immunoassay content of 489 nanograms per ampoule, giving labs worldwide a shared calibration point.11PubMed Central. Establishment of a WHO Reference Reagent for anti-Mullerian hormone
Not every new reference material carries an IU designation. Some are assigned units in nanograms or other mass-based terms when that is more appropriate. The WHO and NIBSC make judgment calls about whether a substance’s biology warrants activity-based units or whether mass-based units will serve just as well. For relatively simple, well-characterized molecules, mass works fine. For complex biologics where manufacturing differences can alter activity without changing mass, IU or similar activity-based units remain the safer choice.
Common Confusions About IU
One of the most frequent misunderstandings is thinking that IU is a universal unit, like a gram or a liter, that means the same thing across all substances. It does not. One IU of vitamin D and one IU of vitamin E represent completely different amounts of mass and completely different biological effects. The only thing they share is that both are defined relative to a reference standard for that specific substance. Comparing IU values across different substances is meaningless.
Another common confusion involves the abbreviation itself. In medical settings, the abbreviation “IU” has been flagged as potentially error-prone in handwritten orders because “IU” can be misread as “IV” (intravenous) or as the number “10.” Some safety organizations recommend writing out “international units” or using “units” instead of the abbreviation in clinical documentation. This is a handwriting and communication issue, not a problem with the measurement system itself, but it is worth knowing if you ever see “units” written out on a prescription instead of the abbreviation.
A third misconception is that IU is an outdated relic being phased out entirely. For vitamins, the shift toward microgram labeling supports that impression. But for the broader universe of biological products, including vaccines, clotting factors, many hormones, and biotherapeutics, the IU system is actively maintained and expanded. New international standards and reference reagents are being created regularly, and the WHO Expert Committee meets on an ongoing basis to review and approve them. The system is very much alive.
Veterinary and Specialized Applications
The IU system is not limited to human medicine. Veterinary vaccines, for instance, are also standardized using international reference preparations. Rabies vaccines for animals are calibrated against the WHO International Standard for rabies vaccine, with regional bodies like the European Directorate for the Quality of Medicines (EDQM) maintaining their own biological reference preparations that are in turn traceable to the WHO standard. This ensures that a rabies vaccine administered to a dog in France meets the same potency threshold as one given in Brazil.
The same logic extends to agricultural applications where biological products need standardized potency measurements, and to laboratory research where scientists need to report results in units that other labs can reproduce. The IU system, for all its quirks, solves a problem that comes up whenever biology introduces variability that pure chemistry does not: you need to measure what something does, not just what it weighs.